Literature DB >> 9860933

Physiological and pathophysiological regulation of cytochrome P450.

E T Morgan1, M B Sewer, H Iber, F J Gonzalez, Y H Lee, R H Tukey, S Okino, T Vu, Y H Chen, J S Sidhu, C J Omiecinski.   

Abstract

This article is a report on a symposium sponsored by the American Society for Pharmacology and Experimental Therapeutics and held at the April 1998 Experimental Biology '98 meeting in San Francisco. The presentations focused on the mechanisms of regulation of cytochrome P450 gene expression by developmental factors and by hormones and cytokines, as well as on the interplay between physiological and chemical regulation. Approaches and systems used to address these questions included conditional gene knockouts in mice, primary hepatocyte cultures, immunofluorescence imaging of cells, and cell lines stably expressing reporter gene constructs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9860933

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  9 in total

1.  p-Anilinoaniline enhancement of dioxin-induced CYP1A1 transcription and aryl hydrocarbon receptor occupancy of CYP1A1 promoter: role of the cell cycle.

Authors:  Althea Elliott; Aby Joiakim; Patricia A Mathieu; Zofia Duniec-Dmuchowski; Thomas A Kocarek; John J Reiners
Journal:  Drug Metab Dispos       Date:  2012-02-16       Impact factor: 3.922

2.  Selective downregulation of hepatic cytochrome P450 expression and activity in a rat model of inflammatory pain.

Authors:  Denis Projean; Sophie Dautrey; Huy Khan Vu; Thierry Groblewski; Jean-Louis Brazier; Julie Ducharme
Journal:  Pharm Res       Date:  2005-01       Impact factor: 4.200

3.  Temporal analysis of hepatocyte differentiation by small hepatocyte-like progenitor cells during liver regeneration in retrorsine-exposed rats.

Authors:  G J Gordon; W B Coleman; J W Grisham
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

Review 4.  Repression of gene expression by oxidative stress.

Authors:  Y Morel; R Barouki
Journal:  Biochem J       Date:  1999-09-15       Impact factor: 3.857

5.  Different alterations of cytochrome P450 3A4 isoform and its gene expression in livers of patients with chronic liver diseases.

Authors:  Li-Qun Yang; Shen-Jing Li; Yun-Fei Cao; Xiao-Bo Man; Wei-Feng Yu; Hong-Yang Wang; Meng-Chao Wu
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

6.  Blood and plasma pharmacokinetics of ciclosporin in diabetic kidney transplant recipients.

Authors:  Anisha E Mendonza; Reginald Y Gohh; Fatemeh Akhlaghi
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

7.  Association of tardive dyskinesia with variation in CYP2D6: Is there a role for active metabolites?

Authors:  Maju M Koola; Evangelia M Tsapakis; Padraig Wright; Shubulade Smith; Robert W Kerwin Rip; Katie L Nugent; Katherine J Aitchison
Journal:  J Psychopharmacol       Date:  2014-03-04       Impact factor: 4.153

8.  Influence of overt diabetes mellitus on cyclosporine pharmacokinetics in a canine model.

Authors:  Khalid M Alkharfy
Journal:  Exp Diabetes Res       Date:  2009-10-20

9.  Direct and cytokine-mediated effects of albumin-fused growth hormone, TV-1106, on CYP enzyme expression in human hepatocytes in vitro.

Authors:  Maciej Czerwiński; Immaculate Amunom; Victor Piryatinsky; Hussein Hallak; Yousif Sahly; Oren Bar-Ilan; Paul Bolliger; Merav Bassan
Journal:  Pharmacol Res Perspect       Date:  2018-04-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.